The present application provides an immunity inducing agent which includes as an active ingredient: at least one polypeptide which exhibits immunity inducing activity and which is selected from (a) polypeptides comprising the amino acid sequences represented by SEQ. ID NO. 8 4 6 10 12 2 and 14 in the sequence listing and polypeptides comprising at least 7 continuous amino acids in said amino acid sequences (b) polypeptides exhibiting at least 85% sequence identity with the amino acid sequences represented by SEQ. ID NO. 8 4 6 10 12 2 and 14 and polypeptides comprising at least 7 continuous amino acids in the amino acid sequences of said polypeptides and (c) polypeptides including as part of the sequences thereof any of the polypeptides in (a) and (b) or a recombinant vector which includes a polynucleotide encoding the abovementioned at least one polypeptide and which is capable of expressing said polypeptide in vivo.
